FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway
MALVERN, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage ...
Hosted on MSN17m
Annovis Bio Stock Among Retail's Top Draws After FDA Nod For Final Phase 3 Alzheimer’s Study Protocol
Annovis Bio Inc. shares saw heightened volatility early Tuesday after the FDA approved the final protocol for its pivotal ...
The Brighterside of News on MSN16m
Aging plays a new role in the fight against Alzheimer's disease
The balance of protein health within cells, a process known as proteostasis, is critical for maintaining cellular ...
Seth Rogen and Wife Lauren Miller Recall ‘Brutal’ Time Navigating Her Mother’s Alzheimer’s in New Doc (Exclusive)
Seth Rogen and wife Lauren Miller Rogen open up to PEOPLE about their upcoming documentary, Taking Care, which shares their ...
Could This Be the Cure? Targeting Protein Imbalances To Stop Alzheimer’s
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
What we know about Alzheimer’s disease in 2024
The Alzheimer’s Association reports that the disease begins as many as two decades before symptoms develop. Physically, the ...
5 things we’ve learned about Alzheimer’s Disease in 2024
The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...
Daily Herald3d
As a doctor, here’s what I have learned from my own Alzheimer’s disease
I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...
How a Common Virus Could Trigger Alzheimer’s Disease
Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...
Pushing back the shadow of Alzheimer’s disease
It should come as no surprise that Alzheimer’s has touched the lives of two individuals designated by President-elect Donald ...
STAT8d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
KSL5d
What we learned about Alzheimer's disease in 2024
SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 ...